— Know what they know.
Not Investment Advice

300453.SZ SHZ

Jiangxi Sanxin Medtec Co.,Ltd.
1W: +0.4% 1M: -4.5% 3M: -3.4% YTD: -4.3% 1Y: +1.0% 3Y: +41.9% 5Y: -14.9%
¥9.05 ($1.35)
+0.02 (+0.22%)
 
SHZ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 41 · ¥4.7B mcap · 510M float · 1.74% daily turnover

Cash Flow Trends

Operating Cash Flow
$390M +14.6% ▲
5Y CAGR: +18.4%
Capital Expenditures
$218M +24.3% ▲
5Y CAGR: +12.1%
Free Cash Flow
$172M +228.7% ▲
5Y CAGR: +31.2%
Dividends Paid
$132M -121.4% ▼
Buybacks
$43M +0.0% ▲
Net Change in Cash
$83M +193.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$129M$172M$199M$207M$248M
Depreciation & Amort.$50M$58M$66M$74M$91M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$83M$80M$101M-$6M$33M
Other Non-Cash Items$11M$20M$37M$71M$18M
Operating Cash Flow$273M$330M$402M$346M$390M
— Investing Activities —
Capital Expenditures-$98M-$175M-$211M-$287M-$218M
Acquisitions (Net)$42K$60K$23K$0$0
Investment Purchases-$937M-$344M-$365M-$507M-$395M
Investment Sales$799M$454M$199M$367M$425M
Other Investing$1M$816K$816K$1M$1M
Investing Cash Flow-$235M-$64M-$376M-$426M-$186M
— Financing Activities —
Net Debt Issuance-$20M-$75M$88M$75M$35M
Stock Repurchased-$79K$0$0$0-$43M
Dividends Paid-$26M-$53M-$59M-$60M-$132M
Other Financing-$5M-$6M$6M-$25M$17M
Financing Cash Flow-$51M-$134M$35M-$9M-$124M
Net Change in Cash-$12M$130M$64M-$88M$83M
Cash End of Period$92M$222M$285M$197M$280M
Free Cash Flow$175M$155M$192M$52M$172M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms